Sector ratings Novartis AG

Stocks

Real-time Estimate Cboe Europe Other stock markets 10:20:12 2026-07-10 EDT			5-day change	1st Jan Change
124.80 ^CHF	+0.40%		-2.41%	+13.91%

07-08	Lancelot Sweden fell 0.8% in June, BioArctic slid despite Eli Lilly deal	FW
07-07	US FDA approves Vera's kidney disease drug	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Fundamentals
NOVARTIS AG	282B	AAA
ELI LILLY AND COMPANY	1,085B	A
JOHNSON & JOHNSON	624B	BBB
ABBVIE INC.	442B	AA	-
ROCHE HOLDING AG	332B	AA
ASTRAZENECA PLC	277B	A
NOVO NORDISK A/S	217B	A
AMGEN INC.	196B	A
GILEAD SCIENCES, INC.	167B	AA
PFIZER INC.	138B	A
VERTEX PHARMACEUTICALS INCORPORATED	126B	AA
BRISTOL-MYERS SQUIBB COMPANY	118B	A
GSK PLC	105B	AA
SANOFI	105B	AA
CHUGAI PHARMACEUTICAL CO., LTD.	74.59B	AA
BAYER AG	56.94B	AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	52.53B	AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	54B	AA
ALNYLAM PHARMACEUTICALS, INC.	41.76B	AA
HALEON PLC	42.54B	AA
Average	226.82B	AA
Weighted average by Cap.		AA